In Turkey, the research & development by business enterprise, pharmaceutical industry in current ppp $ stands at 405.12 million, reflecting an increase of 84.82 million (26.5%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Turkey
No matching regions
Similar regions to Turkey
Business R&D pharmaceutical in current PPP $
More indicators for Turkey
Government R&D in security as % of government support
8.37%
+1.22%
(2021)
Higher-education-finacing R&D financed by general university in local currency
296,259.07M
+138,306.86M
(2022)
R&D financed by rest of the world in local currency
26,425.12M
+10,976.51M
(2022)
Government R&D financed by rest of the world in local currency
1,253.35M
+691.97M
(2022)
Business R&D financed by rest of the world in local currency
17,924.29M
+7,818.67M
(2022)
Turkey Business R&D pharmaceutical in current PPP $ between 2009 and 2021
Period | Business R&D pharmaceutical in current PPP $ | Change |
---|---|---|
2021 | 405.12M | +84.82M |
2020 | 320.29M | +48.30M |
2019 | 271.99M | -122.67M |
2018 | 394.66M | +136.35M |
2017 | 258.31M | -39.67M |
2016 | 297.98M | +82.42M |
2015 | 215.56M | +17.14M |
2014 | 198.42M | +1.93M |
2013 | 196.49M | +8.72M |
2012 | 187.77M | -13.26M |
2011 | 201.03M | +100.94M |
2010 | 100.09M | -1.33M |
2009 | 101.42M |